Cargando…

Argatroban for an alternative anticoagulant in HIT during ECMO

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) have become more frequently used in daily ICU practice, heparin-induced thrombocytopenia (HIT) is a rare but life-threatening complication while on extracorporeal membrane oxygenation (ECMO). HIT confirmation directly impacts on anticoagulant st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rougé, Alain, Pelen, Felix, Durand, Michel, Schwebel, Carole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490178/ https://www.ncbi.nlm.nih.gov/pubmed/28680640 http://dx.doi.org/10.1186/s40560-017-0235-y

Ejemplares similares

Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass
por: Agarwal, Shvetank, et al.
Publicado: (2012)

Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia and Renal Insufficiency Undergoing Orthotopic Heart Transplantation
por: Green, Michael Stuart, et al.
Publicado: (2021)

The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT
por: Koster, Andreas, et al.
Publicado: (2007)

Argatroban for anticoagulation of a blood salvage system - an ex-vivo study
por: Beiderlinden, Martin, et al.
Publicado: (2016)

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
por: McGlynn, Fergal, et al.
Publicado: (2020)

Intravenous enoxaparin as alternative ECMO anticoagulation over a period of 94 days: a case report
por: Durila, Miroslav, et al.
Publicado: (2023)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Argatroban/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?
por: Bredthauer, Andre, et al.
Publicado: (2020)

A Case Report and Literature Review on Argatroban Refractory Heparin-Induced Thrombocytopenia
por: Deen, Imad U., et al.
Publicado: (2022)

Successful Application of Argatroban During VV-ECMO in a Pregnant Patient Complicated With ARDS due to Severe Tuberculosis: A Case Report and Literature Review
por: Wu, Hongxia, et al.
Publicado: (2022)

Argatroban/azd-1222/dexamethasone: Thrombotic thrombocytopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting
por: Klingele, Matthias, et al.
Publicado: (2020)

Awake ECMO without anticoagulation for nearly completely obstructive squamous cell carcinoma of the trachea
por: Klug, Theodore D., et al.
Publicado: (2020)

Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia
por: Ryan, Christine E., et al.
Publicado: (2023)

Argatroban in the management of heparin-induced thrombocytopenia
por: Babuin, Luciano, et al.
Publicado: (2010)

Argatroban/immunostimulants: Vaccine-induced immune thrombotic thrombopenia and lack of efficacy: 3 case reports
Publicado: (2021)

Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017)

Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023)

Minimal invasive extracorporeal circulation an alternative to ECMO in ventricular tachycardia ablation
por: Condello, Ignazio
Publicado: (2023)

Successful Management of Heparin-Induced Thrombocytopenia Using Argatroban in a Very Old Woman: A Case Report
por: Putot, A., et al.
Publicado: (2013)

Argatroban Resistance and Successful Adjunctive Anticoagulation for Cerebral Venous Sinus Thrombosis With SERPINC1 Mutation: A Case Report
por: Ma, Hongrui, et al.
Publicado: (2023)

Uninterrupted Continuation of VV-ECMO Without Anticoagulation for 44 Days in COVID-19 ARDS: A Precarious Quandary
por: Patel, Sankalp P., et al.
Publicado: (2022)

Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS
por: Brückner, Lea, et al.
Publicado: (2021)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
por: Tardy-Poncet, Brigitte, et al.
Publicado: (2015)

Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs
por: Lopez, Mercedes, et al.
Publicado: (2012)

Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function
por: Yeh, Calvin H., et al.
Publicado: (2016)

Argatroban Treatment and Decreased Fibrinogen in a Septic Patient
por: Ajmeri, Aman N, et al.
Publicado: (2020)

Argatroban /AZD-1222/fondaparinux-sodium: Vaccine-induced immune thrombosis with thrombocytopenia and recurrent and fatal intracranial haemorrhage: case report
Publicado: (2021)

ECMO for a polytrauma patient without systemic anticoagulation
por: Abdelaty, Mohamed, et al.
Publicado: (2017)

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
por: Chlebowski, Meghan M., et al.
Publicado: (2020)

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
por: Aliter, Kholoud F., et al.
Publicado: (2020)

Use of Argatroban in Donor Lung Procurement: A Case Report
por: Sharif, Limi, et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Anticoagulation: hitting the target after cardiac surgery
por: Booth, CD, et al.
Publicado: (1999)

Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia
por: Hasan, Haytham, et al.
Publicado: (2023)

VV-ECMO during subsequent segmentectomy after right pneumonectomy
por: Owada-Ozaki, Yuki, et al.
Publicado: (2018)

Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
por: Cashen, Katherine, et al.
Publicado: (2019)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
por: Rajsic, Sasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sv2lvneuojnnqtj07ago9tdepi